Subjects in the GLP-1 RA group had more complications of diabetes (26.0% vs. 18.2%) and a higher occurrence of hypertension (80.9% vs. 75.4%) compared to the DPP-4i group, although these differences were below the minimum SMD threshold of 0.2. This evidence concerns the gene GLP1R and hypertensive disorder.